| Matthew S Bliss, MD | |
|
1504 Madison Ave, Fort Atkinson, WI 53538-3100 | |
| (920) 563-7888 | |
| (920) 563-7741 |
| Full Name | Matthew S Bliss |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 27 Years |
| Location | 1504 Madison Ave, Fort Atkinson, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255378014 | NPI | - | NPPES |
| 34405300 | Medicaid | WI | |
| 60102 | Other | WI | DEAN HEALTH INSURANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 45463-020 (Wisconsin) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 45463-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Memorial Hospital | Fort atkinson, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fort Healthcare Inc | 0840189718 | 130 |
News Archive
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
A new University of Colorado Boulder study indicates an ancient form of complementary medicine may be effective in helping to treat people with mild traumatic brain injury, a finding that may have implications for some U.S. war veterans returning home.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
The 3rd European Iron Academy (EIA) will take place on the 12th and 13th September 2016 in Berlin, Germany, and will bring together over 450 clinicians with an interest in iron deficiency.
› Verified 7 days ago
| Entity Name | Fort Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417993361 PECOS PAC ID: 0840189718 Enrollment ID: O20040319001411 |
News Archive
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
A new University of Colorado Boulder study indicates an ancient form of complementary medicine may be effective in helping to treat people with mild traumatic brain injury, a finding that may have implications for some U.S. war veterans returning home.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
The 3rd European Iron Academy (EIA) will take place on the 12th and 13th September 2016 in Berlin, Germany, and will bring together over 450 clinicians with an interest in iron deficiency.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew S Bliss, MD Po Box 249, Fort Atkinson, WI 53538-0249 Ph: (920) 568-5411 | Matthew S Bliss, MD 1504 Madison Ave, Fort Atkinson, WI 53538-3100 Ph: (920) 563-7888 |
News Archive
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
A new University of Colorado Boulder study indicates an ancient form of complementary medicine may be effective in helping to treat people with mild traumatic brain injury, a finding that may have implications for some U.S. war veterans returning home.
Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.
The 3rd European Iron Academy (EIA) will take place on the 12th and 13th September 2016 in Berlin, Germany, and will bring together over 450 clinicians with an interest in iron deficiency.
› Verified 7 days ago
Dr. Paul W Schuppner, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1504 Madison Ave, Fort Atkinson, WI 53538 Phone: 920-563-7888 Fax: 920-568-7741 | |
Isidoro V Zambrano, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1504 Madison Ave, Fort Atkinson, WI 53538 Phone: 920-563-7888 Fax: 920-563-7741 | |
Thomas J Nordland, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1504 Madison Ave, Fort Atkinson, WI 53538 Phone: 920-563-7888 Fax: 920-563-7741 | |
Stanley E Peterson, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 426 Mcmillen St, Fort Atkinson, WI 53538 Phone: 920-563-7888 Fax: 920-563-7741 |